Vinnova and the Swedish Innovation Hubs aim to develop complimentary linkages and transferable opportunities between Manchester/NW and Sweden. The visit's purpose is to understand how innovation works in Manchester/NW. The programme includes orientation on Manchester's ecosystem including major university and NHS partners, and an overview of TRUSTECH which helps the NHS access innovations through industry collaborations and commercialization support over its 11 years of operation.
Finn Medi Presentation study visit (Life Sciences Sector)TR3S PROJECT
Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.
The document outlines plans for Perak Biotechnology Corporation to become financially independent through various revenue streams and investment opportunities in the biotechnology sector. It proposes developing a biotechnology park and recruiting companies in areas like medical devices, healthcare, and agriculture. Revenue is projected from the life sciences institute, royalties, rentals, and business investments. The plan aims to boost Perak's economy through job creation, exports, and supporting industries from the biotech investments. Approval is requested to implement projects and access state lands to develop the biotechnology park and recruit companies.
European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...patvocates
"European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in empowering patients on medical R&D": Presentation by Jan Geissler (Twitter @jangeissler) at the Belgian Association of Clinical Research Professionals (ACRP.be) meeting on 25 Oct 2012
Polypharmacy and deprescribing safely: a patient-centred method, Professor Nina Barnett Consultant Pharmacist,Care of Older People, London North West Healthcare NHS Trust Medicines Use and Safety Team, Specialist Pharmacy Service
Visiting Professor, Institute of Pharmaceutical Science,
Kings College London
Lessons learned from changing the consultant workforce model in acute medicine.NHS England
Dr Mark Roland, Associate Medical Director from Portsmouth Hospitals NHS Trust describes how the hospital changed their general medical consultant workforce model to improve care and flow. Despite challenges, this has improved care, flow, support for junior teams and staff satisfaction.
The document summarizes the program for the 2nd edition of the Value-Based Health Care Prize. It includes:
- Welcome messages from the chairman and honorary chairman Prof. Michael Porter
- Presentations on enabling VBHC implementation challenges and best practices
- Nominees for the prize across various VBHC initiatives
- Announcement of award winners for patient outcomes, cost-effectiveness and collaboration
- "Value-based care for Parkinson's disease" project wins the overall prize
Finn Medi Presentation study visit (Life Sciences Sector)TR3S PROJECT
Description of the FinnMedi company, an internationally operating company located in Finland and providing services related to research commercialization, business development and clinical research in the Life Sciences sector.
The document outlines plans for Perak Biotechnology Corporation to become financially independent through various revenue streams and investment opportunities in the biotechnology sector. It proposes developing a biotechnology park and recruiting companies in areas like medical devices, healthcare, and agriculture. Revenue is projected from the life sciences institute, royalties, rentals, and business investments. The plan aims to boost Perak's economy through job creation, exports, and supporting industries from the biotech investments. Approval is requested to implement projects and access state lands to develop the biotechnology park and recruit companies.
European Patients’ Academy on Therapeutic Innovation:Shifting paradigms in ...patvocates
"European Patients’ Academy on Therapeutic Innovation: Shifting paradigms in empowering patients on medical R&D": Presentation by Jan Geissler (Twitter @jangeissler) at the Belgian Association of Clinical Research Professionals (ACRP.be) meeting on 25 Oct 2012
Polypharmacy and deprescribing safely: a patient-centred method, Professor Nina Barnett Consultant Pharmacist,Care of Older People, London North West Healthcare NHS Trust Medicines Use and Safety Team, Specialist Pharmacy Service
Visiting Professor, Institute of Pharmaceutical Science,
Kings College London
Lessons learned from changing the consultant workforce model in acute medicine.NHS England
Dr Mark Roland, Associate Medical Director from Portsmouth Hospitals NHS Trust describes how the hospital changed their general medical consultant workforce model to improve care and flow. Despite challenges, this has improved care, flow, support for junior teams and staff satisfaction.
The document summarizes the program for the 2nd edition of the Value-Based Health Care Prize. It includes:
- Welcome messages from the chairman and honorary chairman Prof. Michael Porter
- Presentations on enabling VBHC implementation challenges and best practices
- Nominees for the prize across various VBHC initiatives
- Announcement of award winners for patient outcomes, cost-effectiveness and collaboration
- "Value-based care for Parkinson's disease" project wins the overall prize
Linda Magee - Manchester Academic Health Sciences Network (MAHSC) overviewTRUSTECH
Manchester Academic Health Science Centre (MAHSC) is a partnership of healthcare and research organizations in Manchester, England designated for excellence in research, education, and service. It includes [1] several NHS trusts that serve over 3 million patients annually, [2] the University of Manchester which is a top UK research university, and [3] research infrastructure like the Manchester Cancer Research Centre. MAHSC aims to [1] improve patient care through translation of research into practice, [2] support industry partnerships and economic growth, and [3] train healthcare professionals. It pursues these goals through domains focusing on major disease areas, key research platforms, and partnerships with organizations like the Greater Manchester Academic Health Science Network.
The National Institute for Health Research Collaboration for Leadership in Ap...Richard Harding
This document discusses using funding and partnerships to promote innovation in healthcare technology. It highlights projects in the UK that received funding to develop new technologies, including a children's hospital that leveraged over £13 million for an innovation center. It also describes a competition that provided £500,000 to pilot adoption of new technologies. The document outlines European partnerships and events between countries to support collaboration. It promotes an eHealth cluster to connect businesses, healthcare organizations, and academics. Finally, it discusses challenges of introducing new technologies and the need for organizational changes to accommodate disruptions.
Dr Samantha Roberts: Increasing adoption of innovation Innovation Agency
The NHS England Innovation and Life Sciences Division aims to increase adoption of innovation in healthcare. It oversees numerous programs from initial research through national implementation. The division is working to better align these programs, support behaviors that increase adoption, improve the supply of high quality innovations, and understand demand. It hopes to focus on how to spread innovations adaptively rather than through rigid, top-down approaches.
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
The document discusses innovation and the work of the Innovation Agency. It summarizes the agency's support for businesses, including engaging with 543 companies, providing intensive support to 81 companies, and helping create or safeguard over 100 jobs. It also describes the agency's efforts to foster collaboration through events, awards, and aligning with innovation hubs. The agency provides £500k in funding to pump prime adoption of new technologies and supports challenges to NHS procurement requirements to introduce innovation.
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
The document discusses the Innovation Exchange and SBRI Healthcare programs which aim to accelerate the development and adoption of innovative healthcare solutions in England. It provides background on Karen Livingstone, the director of the programs. It then outlines key forces shaping global healthcare and describes the 15 Academic Health Science Networks that work locally and nationally to drive innovation adoption across England. The rest of the document details how the Innovation Exchange identifies healthcare needs and supports companies through funding competitions, needs assessments, and providing support to help ready solutions for adoption across the NHS. It provides examples of companies it has supported in areas like patient engagement, chronic condition management, and early disease detection.
This document outlines the goals and activities of an organization aimed at spreading innovation in healthcare to improve health outcomes and economic growth. The key points are:
1) The organization aims to spread innovation across the healthcare system, boost the economy through industry growth, and improve equal access to innovative technologies.
2) Activities include supporting the adoption of innovations, developing collaborations between sectors, highlighting opportunities, and bringing together multiple funding streams in the region.
3) The vision is for the region to become a preferred location for healthcare research, trials, collaboration and investment.
The document outlines the agenda for the Northern Innovation and Networking Event 2017 on the adoption and spread of innovation. The event will include presentations on topics such as the importance of innovation, AHSN commercial support for SMEs, and case studies of innovations. Speakers will discuss the AHSN network and its role in improving health and supporting economic growth. The event aims to provide information to help health and life sciences SMEs engage with AHSNs and the NHS to drive the adoption and spread of innovations.
Executive Healthcare Seminar - Belgium - Saudi Arabia - Belgian Embassy RiyadhJan Demey
Belgian and Saudi Healthcare executives met in the Belgian Embassy to discuss several topics in the evolving healthcare market and the Vision 2030 of the Kingdom of Saudi Arabia. The ambition to work together to make healthcare better is our joined ambition. This presentation brings the supporting ideas as discussed during the seminar.
Andy Cairns - Access to Funding Liverpool SME WorkshopInnovation Agency
This document summarizes a funding workshop that discussed various national and European funding opportunities for innovation. It outlines several programs, including:
1) The SBRI Healthcare program which provides up to £100,000 for feasibility studies and up to £1 million for development projects.
2) The Innovation and Technology Payment which aims to support adoption of innovative products and technologies by removing financial barriers.
3) Horizon 2020 and the SME Instrument which provides up to €2.5 million for highly innovative SMEs with global ambitions.
4) Eurostars which provides funding for transnational R&D projects led by SMEs in at least two Eurostars countries.
The workshop emphasized being realistic about
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Julia Re...NHSNWRD
"How are AHSNs good for businiess, academia and the NHS? Case Studies and developing engagement with research and development": Dr Julia Reynold's presentation and workshop explored how key stakeholders (University, NHS and business) are beginning to work with the AHSN, as well as looking at how the approach to working is good for the core business of partner organisations.
This document provides information about the UK Research and Innovation Digital Health Technology Catalyst Round 2 competition. It discusses the UK's industrial strategy and focus on digital health. The competition will invest up to £8 million to fund collaborative industrial research and experimental development projects between small/medium businesses and other organizations. Projects must use digital technologies like AI, VR, sensors and data analytics to improve health outcomes, transform healthcare delivery or control costs. Details are provided on funding amounts, eligibility requirements, project scope and timelines. Interested applicants are encouraged to check the Innovate UK website and attend an information webinar.
New Funding & Development Opportunities for InnovatorsIsabelle Sparrow
On November 8th GM AHSN invited innovators from the region to an event at the Nowgen Centre in Manchester. The event provided information about some of the current funding and support opportunities available to healthcare innovators, including programmes from GM AHSN's Innovation Nexus, SBRI Healthcare and the Business Growth Hub.
The external healthcare environment is changing rapidly and providers are under increasing pressure to innovate with increasing speed and efficiency.
Be it experimenting with new care delivery models to improve care coordination, redesigning workflows to enhance efficiency, or developing new products that improve clinical outcomes, hospitals and their service lines are looking for effective ways to harness the creative power of physicians and employees to solve problems that matter. However, few organizations innovate in an orderly, reliable way.
Great ideas remain captive in the heads of physicians and employees and one-off attempts to spur innovation through “hack-a-thons” and “pitch days” prove disappointing. As an academic medical center and a world leader in orthopedics, Hospital for Special Surgery has a long history of results-oriented innovation.
In this webinar, we will share:
– HSS’ systematic approach for driving innovation
– strategies for generating new insights and developing novel solutions
– processes for piloting and testing new ideas
– guiding principles for creating a culture of innovation
– advice on how to build your very own innovation infrastructure
About the Speaker:
Mark Angelo is Vice President, Innovation & Business Development for Hospital for Special Surgery. Mark joined HSS in 2009 and has held various senior management positions at the Hospital across operations, strategy and business development. As Vice President, Innovation & Business Development, Mark is responsible for advancing hospital strategic priorities related to quality and efficiency, innovation, growth and diversification. One of his key responsibilities includes leading the Operational Excellence program, a hospital-wide initiative that leverages industrial engineering principles to maximize quality and efficiency. Mark also leads the HSS Innovation Center whose mission is to support the development and commercialization of early-stage technologies and solutions.
Prior to joining HSS, Mark worked as a management consultant for Monitor Group where he specialized in operations strategy and organizational design. Mark holds a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto and a Master of Business Administration from Harvard Business School.
Translate: Medical Technologies in the Leeds City Region is a new partnership of universities in the Leeds City Region with world-class expertise in the development of new medical technologies. Translate are working in partnership with DHEZ and the University of Bradford.
East Midlands Academic Health Science Network – igniting innovation Dr Carl...PM Society
The document provides an overview of the East Midlands Academic Health Science Network (EMAHSN). EMAHSN was established to improve healthcare in the East Midlands region of England through innovation and collaboration between the NHS, universities, and industry. The document discusses EMAHSN's goals and functions, geography, vision, operations, and engagement with industry stakeholders to facilitate research, innovation, and adoption of best practices.
This document summarizes support available for small and medium enterprises (SMEs) and innovators on Corridor Manchester. It outlines facilities like Manchester Science Parks that provide office and lab space to over 170 companies in sectors like information and communication technology and healthcare. Other resources mentioned include the MedTech Centre, UMI3, and Innospace for guidance on regulations, product development, and business support. Corridor Manchester aims to facilitate connections between industries, networks, and expertise to promote innovation and business growth.
The document discusses UK Trade & Investment (UKTI), an organization that promotes trade and inward investment. It specifically focuses on UKTI's Life Sciences Investment Organisation (LSIO), which aims to attract investment in UK life sciences by highlighting strengths like research excellence, academic partnerships, and access to the National Health Service. The LSIO will target both existing life sciences companies and disruptive digital health startups. It will create a unified proposition on the UK's offerings and identify ambassador companies to promote this globally.
Linda Magee - Manchester Academic Health Sciences Network (MAHSC) overviewTRUSTECH
Manchester Academic Health Science Centre (MAHSC) is a partnership of healthcare and research organizations in Manchester, England designated for excellence in research, education, and service. It includes [1] several NHS trusts that serve over 3 million patients annually, [2] the University of Manchester which is a top UK research university, and [3] research infrastructure like the Manchester Cancer Research Centre. MAHSC aims to [1] improve patient care through translation of research into practice, [2] support industry partnerships and economic growth, and [3] train healthcare professionals. It pursues these goals through domains focusing on major disease areas, key research platforms, and partnerships with organizations like the Greater Manchester Academic Health Science Network.
The National Institute for Health Research Collaboration for Leadership in Ap...Richard Harding
This document discusses using funding and partnerships to promote innovation in healthcare technology. It highlights projects in the UK that received funding to develop new technologies, including a children's hospital that leveraged over £13 million for an innovation center. It also describes a competition that provided £500,000 to pilot adoption of new technologies. The document outlines European partnerships and events between countries to support collaboration. It promotes an eHealth cluster to connect businesses, healthcare organizations, and academics. Finally, it discusses challenges of introducing new technologies and the need for organizational changes to accommodate disruptions.
Dr Samantha Roberts: Increasing adoption of innovation Innovation Agency
The NHS England Innovation and Life Sciences Division aims to increase adoption of innovation in healthcare. It oversees numerous programs from initial research through national implementation. The division is working to better align these programs, support behaviors that increase adoption, improve the supply of high quality innovations, and understand demand. It hopes to focus on how to spread innovations adaptively rather than through rigid, top-down approaches.
Putting innovation into practice (NHS vs Widnes Vikings)Richard Harding
The document discusses innovation and the work of the Innovation Agency. It summarizes the agency's support for businesses, including engaging with 543 companies, providing intensive support to 81 companies, and helping create or safeguard over 100 jobs. It also describes the agency's efforts to foster collaboration through events, awards, and aligning with innovation hubs. The agency provides £500k in funding to pump prime adoption of new technologies and supports challenges to NHS procurement requirements to introduce innovation.
Karen Livingstone - ECO 17: Transforming care through digital healthInnovation Agency
The document discusses the Innovation Exchange and SBRI Healthcare programs which aim to accelerate the development and adoption of innovative healthcare solutions in England. It provides background on Karen Livingstone, the director of the programs. It then outlines key forces shaping global healthcare and describes the 15 Academic Health Science Networks that work locally and nationally to drive innovation adoption across England. The rest of the document details how the Innovation Exchange identifies healthcare needs and supports companies through funding competitions, needs assessments, and providing support to help ready solutions for adoption across the NHS. It provides examples of companies it has supported in areas like patient engagement, chronic condition management, and early disease detection.
This document outlines the goals and activities of an organization aimed at spreading innovation in healthcare to improve health outcomes and economic growth. The key points are:
1) The organization aims to spread innovation across the healthcare system, boost the economy through industry growth, and improve equal access to innovative technologies.
2) Activities include supporting the adoption of innovations, developing collaborations between sectors, highlighting opportunities, and bringing together multiple funding streams in the region.
3) The vision is for the region to become a preferred location for healthcare research, trials, collaboration and investment.
The document outlines the agenda for the Northern Innovation and Networking Event 2017 on the adoption and spread of innovation. The event will include presentations on topics such as the importance of innovation, AHSN commercial support for SMEs, and case studies of innovations. Speakers will discuss the AHSN network and its role in improving health and supporting economic growth. The event aims to provide information to help health and life sciences SMEs engage with AHSNs and the NHS to drive the adoption and spread of innovations.
Executive Healthcare Seminar - Belgium - Saudi Arabia - Belgian Embassy RiyadhJan Demey
Belgian and Saudi Healthcare executives met in the Belgian Embassy to discuss several topics in the evolving healthcare market and the Vision 2030 of the Kingdom of Saudi Arabia. The ambition to work together to make healthcare better is our joined ambition. This presentation brings the supporting ideas as discussed during the seminar.
Andy Cairns - Access to Funding Liverpool SME WorkshopInnovation Agency
This document summarizes a funding workshop that discussed various national and European funding opportunities for innovation. It outlines several programs, including:
1) The SBRI Healthcare program which provides up to £100,000 for feasibility studies and up to £1 million for development projects.
2) The Innovation and Technology Payment which aims to support adoption of innovative products and technologies by removing financial barriers.
3) Horizon 2020 and the SME Instrument which provides up to €2.5 million for highly innovative SMEs with global ambitions.
4) Eurostars which provides funding for transnational R&D projects led by SMEs in at least two Eurostars countries.
The workshop emphasized being realistic about
Let's Talk Research Annual Conference - 24th-25th September 2014 (Dr Julia Re...NHSNWRD
"How are AHSNs good for businiess, academia and the NHS? Case Studies and developing engagement with research and development": Dr Julia Reynold's presentation and workshop explored how key stakeholders (University, NHS and business) are beginning to work with the AHSN, as well as looking at how the approach to working is good for the core business of partner organisations.
This document provides information about the UK Research and Innovation Digital Health Technology Catalyst Round 2 competition. It discusses the UK's industrial strategy and focus on digital health. The competition will invest up to £8 million to fund collaborative industrial research and experimental development projects between small/medium businesses and other organizations. Projects must use digital technologies like AI, VR, sensors and data analytics to improve health outcomes, transform healthcare delivery or control costs. Details are provided on funding amounts, eligibility requirements, project scope and timelines. Interested applicants are encouraged to check the Innovate UK website and attend an information webinar.
New Funding & Development Opportunities for InnovatorsIsabelle Sparrow
On November 8th GM AHSN invited innovators from the region to an event at the Nowgen Centre in Manchester. The event provided information about some of the current funding and support opportunities available to healthcare innovators, including programmes from GM AHSN's Innovation Nexus, SBRI Healthcare and the Business Growth Hub.
The external healthcare environment is changing rapidly and providers are under increasing pressure to innovate with increasing speed and efficiency.
Be it experimenting with new care delivery models to improve care coordination, redesigning workflows to enhance efficiency, or developing new products that improve clinical outcomes, hospitals and their service lines are looking for effective ways to harness the creative power of physicians and employees to solve problems that matter. However, few organizations innovate in an orderly, reliable way.
Great ideas remain captive in the heads of physicians and employees and one-off attempts to spur innovation through “hack-a-thons” and “pitch days” prove disappointing. As an academic medical center and a world leader in orthopedics, Hospital for Special Surgery has a long history of results-oriented innovation.
In this webinar, we will share:
– HSS’ systematic approach for driving innovation
– strategies for generating new insights and developing novel solutions
– processes for piloting and testing new ideas
– guiding principles for creating a culture of innovation
– advice on how to build your very own innovation infrastructure
About the Speaker:
Mark Angelo is Vice President, Innovation & Business Development for Hospital for Special Surgery. Mark joined HSS in 2009 and has held various senior management positions at the Hospital across operations, strategy and business development. As Vice President, Innovation & Business Development, Mark is responsible for advancing hospital strategic priorities related to quality and efficiency, innovation, growth and diversification. One of his key responsibilities includes leading the Operational Excellence program, a hospital-wide initiative that leverages industrial engineering principles to maximize quality and efficiency. Mark also leads the HSS Innovation Center whose mission is to support the development and commercialization of early-stage technologies and solutions.
Prior to joining HSS, Mark worked as a management consultant for Monitor Group where he specialized in operations strategy and organizational design. Mark holds a Bachelor of Applied Science in Biomedical Engineering from the University of Toronto and a Master of Business Administration from Harvard Business School.
Translate: Medical Technologies in the Leeds City Region is a new partnership of universities in the Leeds City Region with world-class expertise in the development of new medical technologies. Translate are working in partnership with DHEZ and the University of Bradford.
East Midlands Academic Health Science Network – igniting innovation Dr Carl...PM Society
The document provides an overview of the East Midlands Academic Health Science Network (EMAHSN). EMAHSN was established to improve healthcare in the East Midlands region of England through innovation and collaboration between the NHS, universities, and industry. The document discusses EMAHSN's goals and functions, geography, vision, operations, and engagement with industry stakeholders to facilitate research, innovation, and adoption of best practices.
This document summarizes support available for small and medium enterprises (SMEs) and innovators on Corridor Manchester. It outlines facilities like Manchester Science Parks that provide office and lab space to over 170 companies in sectors like information and communication technology and healthcare. Other resources mentioned include the MedTech Centre, UMI3, and Innospace for guidance on regulations, product development, and business support. Corridor Manchester aims to facilitate connections between industries, networks, and expertise to promote innovation and business growth.
The document discusses UK Trade & Investment (UKTI), an organization that promotes trade and inward investment. It specifically focuses on UKTI's Life Sciences Investment Organisation (LSIO), which aims to attract investment in UK life sciences by highlighting strengths like research excellence, academic partnerships, and access to the National Health Service. The LSIO will target both existing life sciences companies and disruptive digital health startups. It will create a unified proposition on the UK's offerings and identify ambassador companies to promote this globally.
The document summarizes Bionow, a business support organization for the biomedical and life sciences sector in northern England. It provides an overview of Bionow's history and services, describes the biomedical sector in northern England, and outlines Bionow's role in connecting universities, hospitals, and companies to support the growth of the region's life science industry.
Rich Ferrie - University of Manchester Innovation GroupTRUSTECH
UMI3 Ltd is the innovation group of the University of Manchester that commercializes intellectual property from the university. It has two divisions - UMIP, which handles intellectual property commercialization, and UMIC, which manages the innovation center. UMIP identifies, protects, and licenses the university's intellectual property. It provides proof-of-principle funding to help early-stage projects address technical risks. To date, UMIP has invested over £9.5 million in proof-of-principle projects and leveraged over £88 million in additional funding.
The document summarizes the work of MIMIT (Manchester Innovations, Manchester Institute of Biotechnology), which identifies unmet clinical needs and funds projects to develop innovative solutions. It has established partnerships between 13 Boston institutions and A*Star Singapore. MIMIT uses a process of scoping unmet needs, validating ideas, awarding funding, and facilitating commercialization outcomes like licensing and spinouts. Several example projects are highlighted that addressed needs like incontinence treatment and received outputs like patents and venture funding.
The document discusses supporting innovation in healthcare to help the NHS meet increasing demands with constrained resources. It notes that simply doing more of what the NHS has always done is no longer an option, and innovation must become core business. The National Innovation Centre (NIC) aims to identify emerging technologies, speed up development, and provide support like identifying unmet needs, prototyping, testing, and helping innovators make their case to the NHS. Several innovative medical devices in development that address unmet clinical needs are also described.
4. Manchester and NW Ecosytem
– Central Manchester University Hospital Foundation Trust - CMFT
• aims to be one of top 5 performing UK research hospitals
• 1mn patient episodes per year with multiple specialist centres
– University of Manchester
• Ranked 38th in world aims to be in top 25 by 2020
• Founder of MAHSC with 6 key hospitals
– Manchester Science Parks
• 25 years of growth
• Tenants include 40 healthcare companies
• Citylabs new 10,000 sq metre bio-health incubator
– NW
• Key assets in universities, hospitals and Industry, especially biotech and
bio pharma, location of NICE
• Culture, Transport and International links second to London
7. TRUSTECH
Improving healthcare through Research and
Innovation
Industry
Help NHS to get the Provide access to NHS
innovations it needs to expertise, helping
deliver improvements companies understand
to care for patients the healthcare needs
of the NHS
8. Why research and innovate?
Improve Save
patient money
outcomes
Increase Improve safety
efficiency
9. Need for Innovation
• Need to save ~ £20 billion –
– can’t do this by cuts and efficiency alone
• QIPP - focus on quality, innovation, productivity and
prevention
– Need NHS to drive up quality whilst improving productivity
– means harnessing and spreading innovation and new ideas
• NHS CEO Innovation Review - Dec 2011
– Innovation must become core business for the NHS
– CQIN payments withheld unless high impact innovations adopted
10. Service to NHS
Identify and develop ideas and innovations
– Identification and Protection (IP)
– Development and Commercialisation
– Project management/Implementation
11. How we do we this for NHS Trusts
– Raise profile of innovation
– Case development and advice
– Introduce new products and services
• schemes, collaborations
12. Raise profile of Innovation
• Provide
– surveys and competitions
– articles for newsletters
– presentations at events
– IP training for staff
– assistance with innovation strategy and policy
13. Case Development and Advice
IP protection
– patents, trade mark, copyright
– IP ownership/use advice
• Commercialisation advice
– Asses commercial potential of innovative services and
products e.g. scale of clinical need, market size,
competition etc
• Business development
– Contract advice - CDAs, collaborations/licences
– Assistance with funding applications
– Company establishment
14. NHS and Industry engagement
• Bringing technology/innovation to the NHS
– Technology scoping – new solutions to NHS requirements
– Framing strengths - attract companies for collaboration
15. NHS Service Outputs
– Currently provide innovation services to 25 NHS
Trusts in the region
– fee based service level-3 tiers
– Generates 40% of TRUSTECH operating costs
17. Service to Companies
Provide access to NHS
– Clinical opinions
– Market research
– Product trials and evaluations
18. How we do this for Companies
• Commercial clinics - for free
• Database of clinical expertise/provide for a fee
– expert opinions
– Route to market/competitor analysis
– Product evaluations
• Access to start up facilities via MedTECH centre
• Operate specific funded programmes to
evaluate products and services in the NHS
20. Company Outputs
– Over 400 companies received support & advice
– Assisted over 150 companies access NHS markets
– Helped get 50 new products into market
– Direct commercial contracts generate about 25% of
TRUSTECH running costs
– Specific funding programmes generate another 35% of
TRUSTECH running costs but are irregular
21. MedTECH Centre
Accelerating Medical Technology Development
NHS Expertise.
Market Research – Focus Groups.
Support with Research Grants.
in situ Clinical Evaluations.
Business Support.
Access to NHS procurement.
Help recruiting students (University of Manchester /
Manchester Business School)
Expert professional advice – IP, Finance, Design.
Systematic access to Clinicians & Patients.
10 minutes walk from Central Manchester’s five hospitals.
Pilot phase of the Royal Eye Hospital Development www.freh.co.uk
Accommodation
Workshop, offices, hot desks.
(superfast broadband, office services, secure 24hr access, parking).
23. Top Tips for success
1. Adopt a mixed economy model early
2. Early successes/case examples are key
3. Proof of Concept funding vital to activate projects
4. Top down and bottom up approach needed for engagement
5. Collaborate with local and national partners
6. Get written into other projects
7. Provide clarity on offering to all clients
8. Strategy needs to be flexible e.g. MedTECH centre
9. Quality staff are a key asset
10. Utilise PR well
So what qualifies me to stand in front of you and talk to you Well originally scientist , molecular oncology got fed up or waiting too long for things to happen So about 12 years ago moved into the development of the outputs of research TrusTECH is an organisation that enables that to happen